verapamil has been researched along with betadex in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| McCandless, R; Yalkowsky, SH | 1 |
| Bergenthal, D; Blaschke, G; Burjanadze, N; Chankvetadze, B; Pintore, G; Strickmann, D | 1 |
| Becirevic-Lacan, M; Pavelic, Z; Skalko-Basnet, N | 1 |
| Lei, Z; Liu, Z; Ni, J; Wu, R; Ye, M; Zou, H | 1 |
| Feng, J; Fu, RN; Gu, JL; Han, JH; Ma, LY; Wang, H | 1 |
| Abe-Dohmae, S; Arakawa, R; Inoue, K; Nishimaki-Mogami, T; Suzuki, S; Tamehiro, N; Tanaka, AR; Ueda, K; Yokoyama, S | 1 |
| Aks, SE; Bryant, SM; Mottram, AR | 1 |
| Baek, JS; Cho, CW | 2 |
| Chen, H; Chen, X; Guo, H; Niu, X; Pan, C; Yi, T | 1 |
| Anojčić, J; GadŽurić, S; Mutić, S; Radanović, D; Vraneš, M | 1 |
11 other study(ies) available for verapamil and betadex
| Article | Year |
|---|---|
Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Calcium Channel Blockers; Cyclodextrins; Drug Stability; Hydrogen-Ion Concentration; Molecular Structure; Solubility; Verapamil | 1998 |
Chiral recognition of verapamil by cyclodextrins studied with capillary electrophoresis, NMR spectroscopy, and electrospray ionization mass spectrometry.
Topics: beta-Cyclodextrins; Calcium Channel Blockers; Cyclodextrins; Electrophoresis, Capillary; Magnetic Resonance Spectroscopy; Mass Spectrometry; Stereoisomerism; Verapamil | 1999 |
Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method.
Topics: Anti-Infective Agents; beta-Cyclodextrins; Cyclodextrins; Drug Carriers; Food Additives; Humans; Liposomes; Metronidazole; Powders; Vasodilator Agents; Verapamil | 2000 |
Enantiomer separation by strong anion-exchange capillary electrochromatography with dynamically modified sulfated beta-cyclodextrin.
Topics: Anions; Atropine; beta-Cyclodextrins; Cyclodextrins; Electrophoresis, Capillary; Metoprolol; Molecular Structure; Praziquantel; Tryptophan; Verapamil | 2001 |
[A novel chiral selector in capillary electrophoresis--beta-cyclodextrin polymer].
Topics: Anti-Allergic Agents; beta-Cyclodextrins; Chlorpheniramine; Cyclodextrins; Electrophoresis, Capillary; Lobeline; Polymers; Stereoisomerism; Vasodilator Agents; Verapamil | 1999 |
Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; beta-Cyclodextrins; Bucladesine; Calcium Channel Blockers; Cell Line; Cholesterol; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxycholesterols; Lipoproteins; Lipoproteins, HDL; Liver X Receptors; Lovastatin; Macrophages; Mice; Nicardipine; Nifedipine; Orphan Nuclear Receptors; Phospholipids; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stereoisomerism; Transfection; Verapamil | 2004 |
Effect of cyclodextrin infusion in a rat model of verapamil toxicity.
Topics: Animals; Apnea; beta-Cyclodextrins; Disease Models, Animal; Heart Arrest; Male; Osmolar Concentration; Oxygen; Rats; Rats, Wistar; Shock, Cardiogenic; Survival Rate; Time Factors; Verapamil | 2011 |
2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Cyclodextrins; Biological Transport; Breast Neoplasms; Calcium Channel Blockers; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Excipients; Female; Humans; MCF-7 Cells; Nanoparticles; Neoplasm Proteins; Paclitaxel; Stearic Acids; Surface-Active Agents; Ultrasonics; Verapamil | 2013 |
Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Cyclodextrins; Biological Transport; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Nanoparticles; Paclitaxel; Poloxamer; Poly(ADP-ribose) Polymerases; Verapamil | 2015 |
A novel in situ strategy for the preparation of a β-cyclodextrin/polydopamine-coated capillary column for capillary electrochromatography enantioseparations.
Topics: beta-Cyclodextrins; Capillary Electrochromatography; Carbazoles; Carvedilol; Epinephrine; Indoles; Isoproterenol; Norepinephrine; Polymers; Propanolamines; Stereoisomerism; Terbutaline; Tryptophan; Verapamil | 2017 |
Electroanalytical performance of a β-cyclodextrin and ionic liquid modified carbon paste electrode for the determination of verapamil in urine and pharmaceutical formulation.
Topics: beta-Cyclodextrins; Carbon; Cyclodextrins; Drug Compounding; Electrodes; Humans; Ionic Liquids; Verapamil | 2021 |